Skip to main content

Table 1 Univariate analysis of clinical characteristics associated with post-operational overall survival in ESCC patients

From: Intronic polymorphisms in genes LRFN2 (rs2494938) and DNAH11 (rs2285947) are prognostic indicators of esophageal squamous cell carcinoma

Characteristics

Patients

Deaths

HR (95% CI)

Log-rank P

n = 287 (%)

n = 82 (%)

Age (years)

61

150 (52.3)

46 (30.7)

1

0.502

 > 61

137 (47.7)

36 (26.3)

0.858 (0.56–1.33)

 

Gender

 Male

187 (65.2)

64 (34.2)

1

0.005

 Female

100 (34.8)

18 (18.0)

0.52 (0.33–0.82)

 

Tumor site

 Upper

16 (5.6)

6 (37.5)

1

0.488

 Middle

252 (87.8)

72 (28.6)

0.675 (0.29–1.55)

 

 Lower

19 (6.6)

4 (21.1)

0.475 (0.13–1.68)

 

Tumor differentiation

 G1

54 (18.8)

10 (18.5)

1

0.101

 G2/G3

233 (81.2)

72 (30.9)

1.58 (0.91–2.74)

 

TNM stage

 I

31 (10.8)

5 (16.1)

1

< 0.001

 II

199 (69.3)

46 (23.1)

1.52 (0.61–3.83)

 

 III

57 (19.9)

31 (54.4)

2.19 (1.36–3.52)

 

Smoking status

 No

170 (59.2)

40 (23.5)

1

0.046

 Yes

117 (40.8)

42 (35.9)

1.57 (1.01–2.44)

 

Drinking status

 No

198 (69.0)

55 (27.8)

1

0.967

 Yes

89 (31.0)

27 (30.3)

1.01 (0.64–1.60)

 
  1. Abbreviations: ESCC esophageal squamous cell carcinoma, HR hazard ratio, CI confidence interval, TNM tumor node metastasis
  2. Log-rank P and HR value were marked bold when it was with a significant level of Log-rank P < 0.05